Skip to content

Morbidity in elderly travelers during a short-term stay abroad, a prospective cohort study

Morbidity in elderly travelers during a short-term stay abroad, a prospective cohort study - ELDEST study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43674
Enrollment
500
Registered
2016-05-18
Start date
2016-07-11
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infecties, verergering onderliggend medisch lijden exacerbation of age-related diseases during travel

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 60 years and older; - Planned travel to the (sub)tropics. (Sub)tropical areas are defined as countries where hepatitis A is endemic and for which vaccination is recommended according to the LCR. -Travel duration of five weeks (35 days) or less. - Ability to complete the questionnaires and diary. - Ability to speak and read Dutch fluently. - Ability to sign the informed consent form.

Exclusion criteria

Exclusion criteria: - 59 years or younger. - Travel to a destination for which no hepatitis A vaccination is recommended according to the LCR. - Inability to complete questionnaires and diary. - Travel duration longer than 5 weeks (>35 days) - Visit to travel clinic is less than two weeks before departure. - Inability to speak or read Dutch. - Inability to complete questionnaire and diary. - Incapacitated travelers. - Absence of written informed consent.

Design outcomes

Primary

MeasureTime frame
The main endpoints of the primary objective are the occurrence, duration in days and morbidity of an acquired illness during travel and four weeks after return. The focus will be on different type of health complaints: - Fever - Gastrointestinal - Respiratory - Dermatological - Cardiovascular - Genitourinary tract Other endpoints of the objective are: - Hand grip strength in kilograms before travel (vitality). - Patient-reported health before, during and after travel (SF-36 and Charlson Comorbidity Index). - Independence in activities of daily living (Katz-ADL). - Cognitive functioning before travel (6CIT).

Secondary

MeasureTime frame
- Frequency of medical conditions before travel (e.g. diabetes mellitus, COPD, cardiovascular disease) - Frequency of medication use before travel - Number of medicines used before travel (e.g. polypharmacy) - Frequency of infectious or non-infectious illnesses during travel or in the Netherlands until four weeks after return - Frequency of a new medical condition or an exacerbation of underlying medical condition during travel or in the Netherlands until four weeks after return - Percentage of medication adjustments during travel and four weeks or in the Netherlands until four weeks after return - Frequency of self-reported compliance with prescribed antimalarials during travel - Frequency of doctor visits abroad or in the Netherlands until four weeks after return - Frequency and duration of hospitalizations abroad or in the Netherlands until four weeks after return Other study parameters Demographical parameters - Gender - Age - Education level - Weight (in kilograms) - Length (in centimetres) - Body Mass Index (BMI), weight/(length in meter2) - Immigrant Travel parameters - Destination - Duration - Type of travel - Type of accommodation - Self-reported risk behaviour during travel (nutrition, hygiene, activities) - Jetlag - Travel health insurance, covering medical costs and repatriation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)